Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q2 2013 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ISHARES TR | 23 | Q2 2024 | 22.9% |
ISHARES TR | 23 | Q2 2024 | 7.2% |
VANGUARD BD INDEX FDS | 23 | Q2 2024 | 7.4% |
VANGUARD CHARLOTTE FDS | 23 | Q2 2024 | 5.9% |
ISHARES TR | 23 | Q2 2024 | 11.1% |
VANGUARD BD INDEX FDS | 23 | Q2 2024 | 3.9% |
ISHARES TR | 23 | Q2 2024 | 3.5% |
VANGUARD INDEX FDS | 23 | Q2 2024 | 3.8% |
VANGUARD BD INDEX FDS | 23 | Q2 2024 | 2.8% |
ABBVIE INC | 23 | Q2 2024 | 1.8% |
View Human Investing LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-28 |
13F-HR | 2024-07-17 |
13F-HR | 2024-04-25 |
13F-HR | 2024-02-12 |
13F-HR | 2023-11-09 |
13F-HR | 2023-08-07 |
13F-HR | 2023-05-10 |
13F-HR | 2023-01-27 |
13F-HR | 2022-10-31 |
13F-HR | 2022-07-27 |
View Human Investing LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.